Carl Weissman serves as the Chairman and CEO of Accelerator. He has been the CEO since its founding in May 2003, and was elevated to Chairman in 2008.
Carl is also a Managing Director at OVP Venture Partners, one of the Accelerator investors and a firm with which he has been affiliated as a Managing Director or previously a Venture Partner since 2006.
Prior to Accelerator, from 2001-2006, Carl was a Venture Partner at MPM Capital (Boston) and in that capacity served as President and CEO of Centagenetix, a Cambridge, MA, human genetics company, prior to founding Accelerator on MPM’s behalf. In his role as CEO of Centagenetix, Carl led the February 2003 merger of Centagenetix, with Elixir Pharmaceuticals, and remained on the Board of Directors of the combined entity until January 2005.
Prior to joining Centagenetix and MPM, he spent six years at Prolinx, Inc., where he held a number of positions, culminating as the head of both Finance and Business Development.
Carl serves on the Board of the Washington Biotechnology and Biomedical Association (WBBA) and the Board of the Oregon Translational Research and Drug Development Institute (OTRADI).